Natural and induced immunization against CCL20 ameliorate experimental autoimmune encephalitis and may confer protection against multiple sclerosis

M Abraham, A Karni, K Mausner-Fainberg, ID Weiss… - Clinical …, 2017 - Elsevier
Th-17 type immune response that occurs in multiple sclerosis (MS) is linked to CCR6-
CCL20 interaction. We confirmed the dependency on CCR6 in EAE development …

CCR 7 ligands are required for development of experimental autoimmune encephalomyelitis through generating IL-23-dependent Th17 cells

T Kuwabara, F Ishikawa, T Yasuda… - The Journal of …, 2009 - journals.aai.org
CCL19 and CCL21 are thought to be critical for experimental autoimmune
encephalomyelitis (EAE) induction, but their precise role is unknown. We examined the role …

CCL22 regulates experimental autoimmune encephalomyelitis by controlling inflammatory macrophage accumulation and effector function

RNE Dogan, N Long, E Forde, K Dennis… - Journal of Leukocyte …, 2011 - academic.oup.com
ABSTRACT EAE is a demyelinating disease of the CNS and serves as a mouse model of
MS. Expression of CCL22 in the draining LNs and spinal cord correlated with the onset of …

Mice deficient for CCR6 fail to control chronic experimental autoimmune encephalomyelitis

A Elhofy, RW DePaolo, SA Lira, NW Lukacs… - Journal of …, 2009 - Elsevier
Chemokines are a superfamily of chemotactic cytokines that play an important role in
leukocyte trafficking and have been implicated as functional mediators of immunopathology …

CCL20/CCR6 chemokine signaling is not essential for pathogenesis in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis

N Sachi, N Kamiyama, B Saechue, S Ozaka… - Biochemical and …, 2023 - Elsevier
Multiple sclerosis is an autoimmune disease in which the immune system attacks the nerve
myelin sheath. The balance between pathogenic Th17 cells and regulatory Treg cells, both …

CCL26 and CCR3 are associated with the acute inflammatory response in the CNS in experimental autoimmune encephalomyelitis

J Shou, J Peng, Z Zhao, X Huang, H Li, L Li… - Journal of …, 2019 - Elsevier
Abstract Chemokine ligand 26 (CCL26) is a member of the eotaxin family. It works by
interacting exclusively with chemokine receptor 3 (CCR3) and acts as an eosinophil …

CC chemokine receptor type 4 antagonist Compound 22 ameliorates experimental autoimmune encephalomyelitis

K Moriguchi, K Miyamoto, N Tanaka, R Ueno… - Journal of …, 2016 - Elsevier
Chemokines and chemokine receptors play important roles in the immune response. We
previously reported the pathogenic role of CC chemokine receptor type 4 (CCR4) in …

CXC chemokine ligand 13 plays a role in experimental autoimmune encephalomyelitis

LV Bagaeva, P Rao, JM Powers… - The Journal of …, 2006 - journals.aai.org
Experimental autoimmune encephalomyelitis (EAE) is a Tcell-mediated autoimmune
disease of the CNS that is widely used as an animal model of multiple sclerosis. In this …

CCL19 is constitutively expressed in the CNS, up-regulated in neuroinflammation, active and also inactive multiple sclerosis lesions

M Krumbholz, D Theil, F Steinmeyer, S Cepok… - Journal of …, 2007 - Elsevier
CCL19 and CCL21 bind to CCR7, which is crucial for both inducing an immune response
and establishing immunological tolerance. We report that in the normal human brain CCL19 …

CCR1 antagonist ameliorates experimental autoimmune encephalomyelitis by inhibition of Th9/Th22-related markers in the brain and periphery

HA Al-Mazroua, A Nadeem, MA Ansari, SM Attia… - Molecular …, 2022 - Elsevier
Multiple sclerosis (MS) is an immune-mediated disease of the central nervous system. The
disease manifestation is associated with the proliferation and activation of lymphocytes and …